Literature DB >> 15272589

[A case of advanced gastric cancer with a tumor embolus in the portal vein successfully treated with TS-1 and CDDP].

Sojun Hoshimoto1, Jun Hagiuda, Naoki Igarashi, Hideo Matsui, Yasumasa Koyama, Makoto Miyakita, Shoji Takanosu.   

Abstract

A 71-year-old man was admitted to our hospital in February 2002 with a diagnosis of advanced gastric cancer with a tumor embolus in the portal vein. TS-1 (120 mg/day) was administered orally daily for 21 days, and CDDP (90 mg/day) was infused intravenously on day 8. After 1 course of this regimen, medication was discontinued in accordance with the patient's request. The patient was readmitted with a history of tarry stools in July 2003. Despite no cancer treatment for almost 1.5 years, the primary lesion and the metastatic lymph nodes had decreased significantly in size and the tumor embolus in the portal vein had disappeared completely on the CT scan. He was therefore treated with TS-1 alone (120 mg/day) under a 4-weeks-on and 2-weeks-off regimen. After 1 course of TS-1 administered alone, the primary lesion showed a further significant decrease in size as viewed by GI endoscopy, and biopsies did not reveal any evidence of malignancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272589

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Successful treatment of advanced gastric adenocarcinoma with portal tumor thrombosis by total gastrectomy following CDDP and S-1 therapy.

Authors:  Sumiya Ishigami; Takaaki Arigami; Keishi Okubo; Ken Sasaki; Hiroshi Kurahara; Yoshikazu Uenosono; Hiroshi Okumura; Tetsuhiro Owaki; Yuko Kijima; Shinichi Ueno; Shoji Natsugoe
Journal:  Clin J Gastroenterol       Date:  2012-05-19

2.  Long-term survival after sequential chemotherapy and surgery for advanced gastric cancer.

Authors:  Takashi Orii; Yukihiko Karasawa; Hiroe Kitahara; Masaki Yoshimura; Motohiro Okumura
Journal:  Int J Surg Case Rep       Date:  2013-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.